From October 26, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 CNY | -2.97% | +2.58% | -23.00% |
04-26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
04-25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-23.00% | 249M | |
+30.63% | 695B | |
+26.51% | 568B | |
-4.63% | 361B | |
+19.57% | 330B | |
+3.79% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.90% | 168B |
- Stock Market
- Equities
- 002826 Stock
- News Tibet AIM Pharm. Inc.
- Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.